Research Paper Volume 15, Issue 17 pp 8664—8691
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
Figure 8. The mRNA expression levels of KIAA1429 in different cell lines. (A) LUAD cell lines, (B) BLCA cell lines, (C) KIRC cell lines. ***P < 0.001; ****P < 0.0001.